A detailed history of Israel Englander (Millennium Management LLC) transactions in Adaptive Biotechnologies Corp stock. As of the latest transaction made, Millennium Management LLC holds 9,400,573 shares of ADPT stock, worth $41.6 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares
9,400,573
Previous 9,262,341 1.49%
Holding current value
$41.6 Million
Previous $33.5 Million 43.55%
% of portfolio
0.02%
Previous 0.02%

Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$3.37 - $5.12 $465,841 - $707,747
138,232 Added 1.49%
9,400,573 $48.1 Million
Q2 2024

Aug 14, 2024

BUY
$2.34 - $3.96 $19.7 Million - $33.4 Million
8,426,580 Added 1008.25%
9,262,341 $33.5 Million
Q1 2024

May 15, 2024

BUY
$2.88 - $4.8 $2.41 Million - $4.01 Million
835,761 New
835,761 $2.68 Million
Q2 2023

Aug 14, 2023

SELL
$6.19 - $8.78 $248,076 - $351,876
-40,077 Reduced 31.3%
87,964 $590,000
Q1 2023

May 15, 2023

SELL
$7.8 - $10.11 $7.18 Million - $9.31 Million
-920,828 Reduced 87.79%
128,041 $1.13 Million
Q4 2022

Feb 14, 2023

BUY
$6.26 - $9.34 $1.61 Million - $2.4 Million
257,045 Added 32.46%
1,048,869 $8.01 Million
Q3 2022

Nov 14, 2022

BUY
$6.5 - $12.67 $870,941 - $1.7 Million
133,991 Added 20.37%
791,824 $5.64 Million
Q2 2022

Aug 15, 2022

BUY
$6.4 - $14.73 $435,251 - $1 Million
68,008 Added 11.53%
657,833 $5.32 Million
Q1 2022

May 16, 2022

BUY
$10.12 - $28.9 $4.44 Million - $12.7 Million
438,640 Added 290.13%
589,825 $8.19 Million
Q4 2021

Feb 14, 2022

BUY
$25.17 - $36.85 $2.9 Million - $4.24 Million
115,078 Added 318.71%
151,185 $4.24 Million
Q3 2021

Nov 15, 2021

BUY
$30.02 - $39.87 $172,164 - $228,654
5,735 Added 18.88%
36,107 $1.23 Million
Q2 2021

Aug 16, 2021

SELL
$32.22 - $44.59 $323,617 - $447,861
-10,044 Reduced 24.85%
30,372 $1.24 Million
Q1 2021

May 17, 2021

SELL
$37.26 - $67.74 $2.76 Million - $5.02 Million
-74,170 Reduced 64.73%
40,416 $1.63 Million
Q4 2020

Feb 16, 2021

SELL
$45.01 - $65.47 $2.54 Million - $3.69 Million
-56,432 Reduced 33.0%
114,586 $6.78 Million
Q3 2019

Nov 14, 2019

SELL
$30.31 - $53.51 $16.3 Million - $28.7 Million
-536,449 Reduced 75.83%
171,018 $5.28 Million
Q2 2019

Aug 15, 2019

BUY
$40.3 - $48.3 $26.4 Million - $31.7 Million
656,022 Added 1275.19%
707,467 $34.2 Million
Q2 2019

Aug 14, 2019

BUY
$40.3 - $48.3 $2.07 Million - $2.48 Million
51,445 New
51,445 $2.43 Million

Others Institutions Holding ADPT

About Adaptive Biotechnologies Corp


  • Ticker ADPT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 142,872,992
  • Market Cap $631M
  • Description
  • Adaptive Biotechnologies Corporation, a commercial-stage company, develops an immune medicine platform for the diagnosis and treatment of various diseases. The company offers immunoSEQ, a platform and core immunosequencing product that is used to answer translational research questions, as well as to discover new prognostic and diagnostic signal...
More about ADPT
Track Israel Englander's Portfolio

Track Israel Englander Portfolio

Follow Israel Englander (Millennium Management LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Millennium Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Millennium Management LLC and Israel Englander with notifications on news.